Workshop: LI-FRAUMENI syndrome

Kurs , 08.05.2019 , Regionalt kompetansesenter for arveleg kreft RKAK

Workshop for health personnel.

bryggen i Bergen
Topics that will be discussed

  • MRI surveillance in Li-Fraumeni syndrome
  • Cancer treatment in TP53 mutation carriers
  • Patient awareness of sarcoma
  • Psychosocial aspects of intensive cancer screening
  • Case presentations

Program Wednesday 8 May

09.00-10.00  Registration

10.00-13.00  Plenary session with the Norwegian Hereditary Cancer Working Group and SSG-meeting participants

Chair: Hildegunn Høberg-Vetti, Western Norway Familial Cancer Center, Haukeland University Hospital, Norway

10.00 Welcome.  Hildegunn Høberg-Vetti

10.05 Introduction to Li-Fraumeni syndrome - history, genetics, cancer risk
Lovise Mæhle, Dep. of Medical Genetics, Oslo University Hospital, Norway

10.25 The use of whole body MRI in surveillance of patients with germline TP53 mutations
Mandy Ballinger, Garvan Institute of Medical Research, Sydney, Australia

10.55 MRI surveillance within the SWEP53-study of patients with germline TP53 mutations in Sweden
Lennart Blomqvist, Department of Imaging and Physiology, Karolinska University Hospital Stockholm, Sweden (t.b.c)

11.25 Short break

11.40 Cancer treatment in patients with a germline TP53 mutation
Hans Petter Eikesdal, Dep. of Oncology, Haukeland University Hospital, Norway

12.00 Raising patient awareness about sarcoma
Ole-Jacob Norum, Division of Orthopaedic Surgery, Oslo University Hospital, Norway

12.15 Psychosocial aspects of intensive cancer screening in Li-Fraumeni syndrome
Mandy Ballinger, Garvan Institute of Medical Research, Sydney, Australia

12.45 Discussion

13.00–14.00 Lunch 

14.00-16.30  Workshop Li-Fraumeni syndrome

Chair: Lovise Mæhle

NB! Please bring cases that you would like to discuss in the closed workshop after lunch. The presentations should be short (maximum 3 slides per case) and anonymized.

14.00 Surveillance of patients with germlineTP53 mutations in Denmark
Karin Wadt, Dep. of Medical Genetics, Rigshospitalet, København, Denmark

14.15 Surveillance of patients with germline TP53 mutations in Norway
Lars Fredrik Engebretsen, Dep. of Medical Genetics, St. Olav’s Hospital, Trondheim

14.30 The challenges in establishing a national surveillance study – experiences from SWEP53
Svetlana Bajalica-Lagercrantz, Dep.of Oncology-Pathology, Karolinska University Hospital Stockholm, Sweden

15.00 Short break

15.15 Case presentations.  By participants

15:45 ERN Genturis guidelines for Li-Fraumeni syndrome.  Svetlana Bajalica-Lagercrantz

16:00 The next steps. Scandinavian collaboration?

16:30 move to…

16.40-17.00 Joint session with Scandinavian Sarcoma Group Plenary meeting

16.40 Genetics and oncological therapy. D. Thomas, Sydney

 

(Minor changes to the program may occur)

Registration

Registration fee: NOK 1200
Registration deadline: 1. April 2019

Online registration link

Når og kor

Dato
08.05.2019 
Klokkeslett
09:00-17:00
Stad
Grand Hotel Terminus, Zander Kaaes Gate 6, 5015 Bergen, Norway
+47 55 21 25 00
 
Arrangør
Regionalt kompetansesenter for arveleg kreft RKAK
Organised by the Western Norway Familial Cancer Center In association with the Norwegian working group for hereditary cancer and the Scandinavian Sarcoma Group SSG. 
Meir informasjon
*Scandinavian Sarcoma Group SSG  
Fann du det du leita etter?
Tilbakemeldinga vil ikkje bli svart på. Ikkje send personleg informasjon, for eksempel epost, telefonnummer eller personnummer.